This combination medication contains Telmisartan 40 mg and Metoprolol Tartrate extended-release (ER) 50 mg/25 mg. It is specifically formulated to manage hypertension (high blood pressure) and reduce the risk of cardiovascular events such as heart attack and stroke. Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, making it easier for the heart to pump blood. Metoprolol Tartrate (ER) is a beta-blocker that slows down the heart rate and reduces the heart’s workload. Together, this combination provides enhanced blood pressure control and cardiovascular protection. The extended-release form ensures stable, long-acting effects with once-daily dosing.
